Literature DB >> 12645807

Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis.

Concepcíon Cassinello1, Enrique Moreno, Adolfo Gozalo, Blanca Ortuño, Beatriz Cuenca, José Antonio Solís-Herruzo.   

Abstract

The effects of Orthotopic liver transplantation (OLT) on renal function and major vasoactive factors was assessed in end-stage cirrhotic patients. Renal function, mean arterial pressure, and plasma vasoactive hormones were measured In 22 cirrhotic patients with refractory ascites before and after OLT. Before OLT, mean arterial pressure, glomerular filtration rate, free water clearance, and fractional sodium excretion serum sodium levels were decreased. In addition, serum creatinine and plasma levels of vasoactive factors were increased. Ten of these patients fulfilled criteria of hepatorenal syndrome (HRS). Nine to 12 months after transplantation, renal function had improved and plasma levels of vasoactive factors had decreased significantly in all patients, including those with HRS. However, glomerular filtration rate remained subnormal and plasma endothelin-1 levels and plasma renin activity remained increased in most of them. In conclusion, OLT improves renal function in patients with end-stage liver cirrhosis, including those with HRS. However, renal function remains subnormal in most of these patients.

Entities:  

Mesh:

Year:  2003        PMID: 12645807     DOI: 10.1023/a:1021763221337

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  66 in total

1.  Pretransplant renal dysfunction predicts poorer outcome in liver transplantation.

Authors:  R A Lafayette; G Paré; C H Schmid; A J King; R J Rohrer; S A Nasraway
Journal:  Clin Nephrol       Date:  1997-09       Impact factor: 0.975

2.  Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation.

Authors:  S Bachmann-Brandt; I Bittner; P Neuhaus; U Frei; R Schindler
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

3.  Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation.

Authors:  S C Textor; D J Wilson; A Lerman; J C Romero; J C Burnett; R Wiesner; E R Dickson; R A Krom
Journal:  Transplantation       Date:  1992-07       Impact factor: 4.939

4.  Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.

Authors:  P S Kamath; H A Carpenter; R V Lloyd; M A McKusick; J L Steers; D M Nagorney; V M Miller
Journal:  Liver Transpl       Date:  2000-09       Impact factor: 5.799

5.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

6.  Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.

Authors:  V Arroyo; J Bosch; M Mauri; F Ribera; F Navarro-López; J Rodés
Journal:  Eur J Clin Invest       Date:  1981-06       Impact factor: 4.686

7.  Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index.

Authors:  A Maroto; A Ginès; J Saló; J Clària; P Ginès; L Anibarro; W Jiménez; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

8.  The long-term course of cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; R Sibley; L Newton; S J Tomlanovich; C Boshkos; E Stinson; J A Luetscher; D J Whitney; D Krasny; N S Coplon
Journal:  Kidney Int       Date:  1988-02       Impact factor: 10.612

9.  Effect of intrathoracic pressure on plasma arginine vasopressin levels.

Authors:  J A Solis-Herruzo; D Moreno; A Gonzalez; L Larrodera; G Castellano; J Gutierrez; A Gozalo
Journal:  Gastroenterology       Date:  1991-09       Impact factor: 22.682

10.  Preoperative risk factor assessment in liver transplantation.

Authors:  P Baliga; R M Merion; J G Turcotte; J M Ham; K S Henley; M R Lucey; A Schork; Y Shyr; D A Campbell
Journal:  Surgery       Date:  1992-10       Impact factor: 3.982

View more
  11 in total

Review 1.  Recent advances in our understanding of hepatorenal syndrome.

Authors:  Florence Wong
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

2.  The course of type 1 hepato-renal syndrome post liver transplantation.

Authors:  Paul E Marik; Kelly Wood; Thomas E Starzl
Journal:  Nephrol Dial Transplant       Date:  2005-10-25       Impact factor: 5.992

3.  Treatment to improve acute kidney injury in cirrhosis.

Authors:  Florence Wong
Journal:  Curr Treat Options Gastroenterol       Date:  2015-06

4.  Urinary neutrophil gelatinase-associated lipocalin determines short-term mortality and type of acute kidney injury in cirrhosis.

Authors:  Suhas Udgirkar; Pravin Rathi; Nikhil Sonthalia; Sanjay Chandnani; Qais Contractor; Ravi Thanage; Samit Jain
Journal:  JGH Open       Date:  2020-07-03

5.  Hepatorenal syndrome: current management.

Authors:  Florence Wong
Journal:  Curr Gastroenterol Rep       Date:  2008-02

6.  Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.

Authors:  Elizabeth C Verna; Robert S Brown; Erica Farrand; Elsa M Pichardo; Catherine S Forster; David A Sola-Del Valle; Sarah H Adkins; Meghan E Sise; Juan A Oliver; Jai Radhakrishnan; Jonathan M Barasch; Thomas L Nickolas
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

7.  Impact of Propranolol on Preventing Renal Dysfunction in Patients with Cirrhosis.

Authors:  Kambiz Akhavan Rezayat; Abbas Ali Zeraati; Masoud Pezeshki Rad; Jalal Chogan; Najmeh Davoudian; Amir Akhavan Rezayat; Seyed Mousalreza Hoseini
Journal:  Middle East J Dig Dis       Date:  2017-10

8.  Clinical Outcomes after Liver Transplantation for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Piyapon Utako; Thapanakul Emyoo; Thunyarat Anothaisintawee; Noriyo Yamashiki; Ammarin Thakkinstian; Abhasnee Sobhonslidsuk
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

9.  Urinary biomarkers of acute kidney injury in patients with liver cirrhosis.

Authors:  Anass Ahmed Qasem; Salama Elsayed Farag; Emad Hamed; Mohamed Emara; Ahmed Bihery; Heba Pasha
Journal:  ISRN Nephrol       Date:  2014-04-06

10.  Urinary biomarkers of acute kidney injury in patients with liver cirrhosis.

Authors:  Qasem Anass Ahmed; Farag Salama El Sayed; Hamed Emad; Emara Mohamed; Bihery Ahmed; Pasha Heba
Journal:  Med Arch       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.